Author

Julia Ford

Observed name: J Ford

Institution: Gossamer Bio (United States)

Observed institution: Gossamer Bio (United States)

OpenAlex ID: A5113567077

Randomised clinical trial: a phase 1b study of GB004, an oral HIF‐1α stabiliser, for treatment of ulcerative colitis

2022 · Silvio Danese, Barrett G. Levesque, et al. · Alimentary Pharmacology & Therapeutics · 35

DOP05 Target engagement and pharmacodynamic biomarker analysis following treatment with the oral gut-targeted HIF-1α stabilizer GB004 in a Phase 1b trial in Active Ulcerative Colitis

2021 · W Sandborn, Z Ding, et al. · Journal of Crohn s and Colitis · 1

Editorial: protecting hypoxia‐inducible factor 1a and gut integrity with GB 004—a promising therapeutic approach for ulcerative colitis? Authors' reply

2022 · Silvio Danese, Barrett G. Levesque, et al. · Alimentary Pharmacology & Therapeutics

Works count: 3

Citation count: 36

H-index: 1

I10-index: 1